tiprankstipranks
BioStem Technologies (BSEM)
:BSEM
US Market

BioStem Technologies (BSEM) Financial Statements

Compare
180 Followers

BioStem Technologies Financial Overview

BioStem Technologies's market cap is currently $251.13M. The company's EPS TTM is $0.637; its P/E ratio is 21.65; BioStem Technologies is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 16.69M$ 6.88M$ 4.34M$ 2.52M$ 2.63M
Gross Profit$ 15.42M$ 5.99M$ 2.87M$ 1.25M$ 1.31M
Operating Income$ -7.78M$ -4.68M$ -1.61M$ -1.84M$ -5.73M
EBITDA$ -7.55M$ -6.52M$ -602.00K$ -1.59M$ -5.38M
Net Income$ -8.48M$ -7.07M$ -1.45M$ -2.39M$ -6.38M
Balance Sheet
Cash & Short-Term Investments$ 239.41K$ 772.14K$ 340.33K$ 100.70K$ 140.74K
Total Assets$ 14.56M$ 3.47M$ 2.67M$ 2.67M$ 3.15M
Total Debt$ 4.77M$ 5.09M$ 4.83M$ 5.63M$ 5.11M
Net Debt$ 4.53M$ 4.32M$ 4.49M$ 5.52M$ 4.97M
Total Liabilities$ 15.90M$ 7.42M$ 8.47M$ 8.30M$ 7.09M
Stockholders' Equity$ -1.34M$ -4.08M$ -5.96M$ -5.80M$ -4.09M
Cash Flow
Free Cash Flow$ -3.60M$ -2.11M$ -152.29K$ -585.25K$ -979.38K
Operating Cash Flow$ -3.50M$ -1.64M$ -109.44K$ -581.57K$ -845.79K
Investing Cash Flow$ -210.33K$ -469.48K$ -7.85K$ -3.69K$ 45.41K
Financing Cash Flow$ 3.18M$ 573.12K$ 357.42K$ 541.52K$ -235.03K
Currency in USD

BioStem Technologies Earnings and Revenue History

BioStem Technologies Debt to Assets

BioStem Technologies Cash Flow

BioStem Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis